About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1857 record(s)
Req # A-2021-000844
Adverse Drug Reactions (ADRs) for PETHIDINE HYDROCHLORIDE. Report numbers: E2B_03497961, E2B_03491971, E2B_03304369, E2B_03282744, E2B_03326776.Organization: Health Canada
December 2021
Req # A-2021-000858
Adverse Drug Reactions (ADRs) for VALPROIC ACID. Report numbers: E2B_03474423, E2B_03467353.Organization: Health Canada
December 2021
Req # A-2021-000887
Adverse Drug Reaction (ADR) for Alburex 25. Report number: 03850751.Organization: Health Canada
December 2021
Req # A-2021-000890
Adverse Drug Reactions (ADRs). Report numbers: E2B_03284687, E2B_03285899, E2B_03327646, E2B_03322159, E2B_03331594, E2B_03331596, E2B_03337894, E2B_03337982, E2B_03343260, E2B_03343357, E2B_03343408, E2B_03343620, E2B_03351281.Organization: Health Canada
December 2021
Req # A-2021-000929
Adverse Drug Reactions (ADRs). Report numbers: E2B_02501457, 000732985, 000736581, E2B_02775069, 000734877, 000736586, E2B_02777092, E2B_02777096, E2B_02777071, E2B_03663702, 000933444, E2B_03473106, E2B_03652817, E2B_03805727, E2B_02904223, E2B_02573480, E2B_02757333, E2B_03150979, 000921564, E2B_03406737.Organization: Health Canada
December 2021
Req # A-2021-000966
Adverse Drug Reaction (ADR) for Rexulti. Report number: 000950477. ADR for Abilify Maintena. Report number: E2B_04221351. ADRs for Abilify. Report numbers: E2B_04212548, E2B_04212523, E2B_04178373, E2B_04140561. ADRs for Aripiprazole. Report numbers: 000960212, 000953653.Organization: Health Canada
December 2021
Req # A-2021-000987
Adverse Drug Reactions (ADRs) for Vedolizumab. Report numbers: E2B_04124210,E2B_04109790, E2B_04185970, E2B_04118452, E2B_04228594. ADRs for Ondansetron. Report numbers: E2B_04198175, E2B_04166817, 952157, 953433. ADR for Pantoloc. Report number: 951454. ADRs for Pantoprazole sodium. Report numbers: E2B_04142970, E2B_04186572, E2B_04175116, E2B_04129042, E2B_04122589, E2B_04219291, 951454. ADR for Tecta. Report number: 951343.Organization: Health Canada
December 2021
Req # A-2021-000991
Adverse Drug Reactions (ADRs) for DOCETAXEL. Report numbers: 000931951, 000934737, E2B_03760356, 000934784, E2B_03664912, E2B_03645381, 000936801, 000934927, E2B_03553225, 000935107, 000931424, 000934690, E2B_03554178, 000933261, E2B_03533025, 000936480, E2B_03583109, E2B_03625412.Organization: Health Canada
December 2021
Req # A-2021-000993
Adverse Drug Reaction (ADR) for MORPHINE. Report number: E2B_04186461. ADRs for HYDROMORPHONE. Report numbers: 000950415, 000950520, E2B_04175194. ADR for HEPARIN. Report number: 000950543. ADRs for MIDAZOLAM. Report number: 000949299, 000950317, 000952239.Organization: Health Canada
December 2021
Req # A-2021-001004
Adverse Drug Reaction (ADR) for DANAZOL. Report number: E2B_03717418.Organization: Health Canada
December 2021